pbm glp-1 news What to know about the Trump deal on weight-loss drugs Five Key PBM Trends to

Herein, we successfully switched a patient with acromegaly from a dipeptidyl peptidase-4 (DPP-4) inhibitor to a glucagon-like peptide-1 (GLP-1) analog due to pasireotide-induced deterioration of glycemic control, and we examined the underlying mechanism for glycemic control

INTRODUCTION Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition associated with significant physical, economic, and psychosocial burdens.1 It is characterized by painful follicular occlusions, primarily at intertriginous locations, which...

In this guideline, we update the pharmacotherapy recommendations in the 2020 Canadian clinical practice ...

New data on Hengrui Pharma and Kailera Therapeutics investigational oral GLP-1 have validated the late-stage weight loss asset and paved the road for a regulatory submission in China, but analysts pointed to high rates of nausea and vomiting that could challenge the ongoing U.S

Learn the VA's coverage rules, eligibility criteria, and how to access GLP-1 medications like Ozempic through veteran benefits.

Worried about appetite suppressant side effects